Hidradenitis suppurativa:: are tumour necrosis factor-α blockers the ultimate alternative?

被引：41
|
作者：
Brunasso, A. M. G. [2 ,3 ]
Delfino, C. [3 ]
Massone, C. [1 ]
机构：
[1] Med Univ Graz, Res Unit Dermatopathol, Dept Dermatol, A-8036 Graz, Austria
[2] Galliera Hosp, Dept Dermatol, Genoa, Italy
[3] Univ Florence, Sch Med, Dept Dermatol Sci, Florence, Italy
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2008年 / 159卷 / 03期
关键词：
hidradenitis suppurativa; infliximab; tumour necrosis factor-alpha;
D O I：
10.1111/j.1365-2133.2008.08735.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：761 / 763
页数：4
相关论文
共 50 条
  • [1] Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-α Inhibitors
    Haslund, Pia
    Lee, Robert A.
    Jemec, Gregor B. E.
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) : 595 - 600
  • [2] Increased Serum Tumour Necrosis Factor-α in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-α Agents?
    Matusiak, Lukasz
    Bieniek, Andrzej
    Szepietowski, Jacek C.
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) : 601 - 603
  • [3] Tumour necrosis factor-α blockers in the treatment of psoriasis
    Lebwohl, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (06) : 1169 - 1171
  • [4] Blockers of tumour necrosis factor-α: mechanisms of action
    Eder, Piotr
    Lykowska-Szuber, Liliana
    Stawczyk-Eder, Kamila
    Krela-Kazmierczak, Iwona
    Linke, Krzysztof
    PRZEGLAD GASTROENTEROLOGICZNY, 2011, 6 (05): : 290 - 298
  • [5] Paradoxical psoriasiform reactions to antitumour necrosis factor-α drugs in hidradenitis suppurativa
    Dequidt, L.
    Cogrel, O.
    Guillet, S.
    Milpied, B.
    Darrigade, A. S.
    Beylot-Barry, M.
    Pham-Ledard, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : 281 - 283
  • [6] Are there effects of tumour necrosis factor-α blockers on male fertility?
    Colsman, A.
    Kiesewetter, F.
    Heppt, F.
    Sticherling, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E158 - E158
  • [7] Tumour necrosis factor-α inhibitor prescription patterns for hidradenitis suppurativa in the united states veterans affairs healthcare system
    Rypka, Katelyn J.
    Wendland, Zachary
    Herzog, Claire
    Greenlund, Lindsey
    Agiri, Fatai Y.
    Perez, Cristina
    DuVall, Scott L.
    Orenstein, Lauren
    Lynch, Julie A.
    Goldfarb, Noah I.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 124 - 125
  • [8] The potential cost-savings of tumour necrosis factor inhibitors for hidradenitis suppurativa
    Micheletti, R. G.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 988 - 989
  • [9] Antidrug antibodies to tumour necrosis factor inhibitors in hidradenitis suppurativa: a systematic review
    Lu, J. D.
    Milakovic, M.
    Piguet, V.
    Alavi, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : 555 - 557
  • [10] Tumour Necrosis Factor-α Blockers in Rheumatoid ArthritisReview of the Clinical Experience
    Corinne Richard-Miceli
    Maxime Dougados
    BioDrugs, 2001, 15 : 251 - 259
12345